0001127602-19-034132.txt : 20191203 0001127602-19-034132.hdr.sgml : 20191203 20191203162530 ACCESSION NUMBER: 0001127602-19-034132 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191202 FILED AS OF DATE: 20191203 DATE AS OF CHANGE: 20191203 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WHITE ROBERT JOHN CENTRAL INDEX KEY: 0001726709 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36820 FILM NUMBER: 191266068 MAIL ADDRESS: STREET 1: MEDTRONIC PLC STREET 2: 710 MEDTRONIC PKWY MS LC300 CITY: MINNEAPOLIS STATE: MN ZIP: 55432 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Medtronic plc CENTRAL INDEX KEY: 0001613103 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 000000000 FISCAL YEAR END: 0424 BUSINESS ADDRESS: STREET 1: 20 ON HATCH, LOWER HATCH STREET CITY: DUBLIN STATE: L2 ZIP: 2 BUSINESS PHONE: 01135314381700 MAIL ADDRESS: STREET 1: 20 ON HATCH, LOWER HATCH STREET CITY: DUBLIN STATE: L2 ZIP: 2 FORMER COMPANY: FORMER CONFORMED NAME: Medtronic Ltd DATE OF NAME CHANGE: 20150112 FORMER COMPANY: FORMER CONFORMED NAME: Medtronic Holdings Ltd DATE OF NAME CHANGE: 20140711 FORMER COMPANY: FORMER CONFORMED NAME: Kalani I Ltd DATE OF NAME CHANGE: 20140709 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2019-12-02 0001613103 Medtronic plc MDT 0001726709 WHITE ROBERT JOHN MEDTRONIC PLC 710 MEDTRONIC PKWY MS LC300 MINNEAPOLIS MN 55432 1 EVP & President MITG Ordinary Shares 2019-12-02 4 M 0 25442 47.00 A 77510 D Ordinary Shares 2019-12-02 4 M 0 26724 74.84 A 104234 D Ordinary Shares 2019-12-02 4 S 0 13484 110.285 D 90750 D Ordinary Shares 2019-12-02 4 S 0 13240 110.973 D 77510 D Ordinary Shares 2019-12-02 4 S 0 12859 110.28 D 64651 D Ordinary Shares 2019-12-02 4 S 0 12583 110.973 D 52068 D Stock Option (Right to Buy) 47.00 2019-12-02 4 M 0 25442 0 D 2014-12-02 2023-12-01 Ordinary Shares 25442 0 D Stock Option (Right to Buy) 74.84 2019-12-02 4 M 0 26724 0 D 2018-06-29 2025-01-27 Ordinary Shares 26724 0 D The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.72 to $110.70, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc or the staff of the Securities and Exchange commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.73 to $111.51, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc or the staff of the Securities and Exchange commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.73 to $110.72, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc or the staff of the Securities and Exchange commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.76 to $111.54, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc or the staff of the Securities and Exchange commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. /s/ Perry F. Sekus, attorney-in-fact 2019-12-03